· Tempus AI, Inc. (NASDAQ: TEM) started 2025 announcing the National Launch of its FDA -approved xT CDx Test, a 648-gene next-generation sequencing test for solid tumor profiling, which includes ...
Kenya has ended a three-week vaccine stockout with the distribution of 2.3 million doses of BCG and seven million doses of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback